HLA-A*0201 | B2M & HIV Gag

お問い合わせ

HLA-A*0201 | B2M & HIV Gagバックグランド

HIV (human immunodeficiency virus) is a virus that attacks the body’s immune system. If HIV is not treated, it can lead to AIDS (acquired immunodeficiency syndrome). It can be transmitted via the exchange of a variety of body fluids from infected people, such as blood, breast milk, semen and vaginal secretions, And from a mother to her child during pregnancy and delivery. This disease can be managed by treatment regimens composed of a combination of antiretroviral (ARV) drugs. The Human HLA-A*0201 HIV (SLYNTVATL) complex protein is a complex of HLA-A*0201 of the MHC Class I, B2M, and SLYNTVATL peptide of the HIV.

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
KLS-2031KLS-2031Phase 2 ClinicalKolon Life Science. IncRadiculopathy
詳細
NGM-386NGM-386Phase 1 ClinicalNgm Biopharmaceuticals IncObesity
詳細
NGM-395NGM-395Phase 1 ClinicalNgm Biopharmaceuticals IncMetabolic Dysfunction-Associated Steatotic Liver Disease; Obesity
詳細
  • お問い合わせ
  • 治験薬に関する情報
お問い合わせ

お問い合わせ
グローバル:+1 800-810-0816(Toll Free)

メールアドレス
order.jp@acrobiosystems.com

アクロバイオシステムズ株式会社
〒101-0051
東京都千代田区神田神保町1-32-8